By Fraiser Kansteiner for Fierce Pharma
“Novartis believes a former employee of its Egyptian affiliate made off with thousands of files before jumping ship to Takeda. Now, the Swiss pharma giant wants a peek at Takeda’s business records to find out whether any of its confidential information has been used improperly.
In a complaint for discovery filed earlier this week in Massachusetts Superior Court, Novartis accused ex-staffer Khaled Shams Eldin—who’d most recently served as operations lead for cell and gene therapy at Novartis’ Egypt branch—of transferring some 10,000 files to his personal email about a month before his departure from the company on May 31, 2023.
Bloomberg Law, Stat and other publications reported on the case Wednesday…”
Continue reading at the original source, linked here.






